Total Payments
$26,872
2024 Payments
$1,889
Companies
35
Transactions
710
Medicare Patients
3,290
Medicare Billing
$496,747
Payment Breakdown by Category
Food & Beverage$13,409 (49.9%)
Consulting$12,650 (47.1%)
Education$557.00 (2.1%)
Travel$256.75 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,409 | 691 | 49.9% |
| Consulting Fee | $12,650 | 3 | 47.1% |
| Education | $557.00 | 14 | 2.1% |
| Travel and Lodging | $256.75 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $16,082 | 161 | $0 (2024) |
| Gilead Sciences, Inc. | $2,943 | 149 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,716 | 90 | $0 (2024) |
| Janssen Biotech, Inc. | $1,142 | 77 | $0 (2023) |
| Theratechnologies Inc. | $979.10 | 50 | $0 (2024) |
| ABBVIE INC. | $821.78 | 33 | $0 (2024) |
| Insmed, Inc. | $708.93 | 27 | $0 (2024) |
| Janssen Products, LP | $372.85 | 6 | $0 (2022) |
| Allergan, Inc. | $343.75 | 29 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $317.49 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,889 | 78 | Gilead Sciences, Inc. ($633.44) |
| 2023 | $2,051 | 101 | ViiV Healthcare Company ($407.28) |
| 2022 | $2,186 | 112 | Gilead Sciences, Inc. ($582.06) |
| 2021 | $1,658 | 76 | ViiV Healthcare Company ($389.84) |
| 2020 | $8,680 | 79 | ViiV Healthcare Company ($7,774) |
| 2019 | $1,558 | 81 | Gilead Sciences, Inc. ($453.89) |
| 2018 | $7,370 | 92 | ViiV Healthcare Company ($6,100) |
| 2017 | $1,481 | 91 | ViiV Healthcare Company ($220.89) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: HIV | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.59 | General |
| 12/12/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: HIV | ||||||
| 12/10/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 11/27/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: HIV | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: HIV | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.09 | General |
| 11/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.70 | General |
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.66 | General |
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.46 | General |
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.28 | General |
| 10/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: HIV | ||||||
| 10/23/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: HIV | ||||||
| 10/17/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: HIV | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/01/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: HIV | ||||||
| 09/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: HIV | ||||||
| 09/18/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: HIV | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.32 | General |
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.18 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 713 | 1,172 | $190,788 | $95,754 |
| 2022 | 8 | 730 | 1,187 | $195,890 | $98,599 |
| 2021 | 7 | 863 | 1,571 | $269,449 | $142,336 |
| 2020 | 10 | 984 | 1,958 | $322,869 | $160,058 |
Total Patients
3,290
Total Services
5,888
Medicare Billing
$496,747
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 276 | 672 | $73,920 | $42,067 | 56.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 195 | 217 | $54,250 | $22,410 | 41.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 125 | 131 | $40,872 | $17,976 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 97 | $14,550 | $9,079 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 30 | $2,940 | $1,950 | 66.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $1,829 | 52.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $756.14 | $443.52 | 58.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 286 | 684 | $75,240 | $38,641 | 51.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 164 | 171 | $53,352 | $26,730 | 50.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 148 | 155 | $38,750 | $16,622 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 117 | $17,550 | $10,527 | 60.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,100 | $2,740 | 53.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 16 | $3,616 | $2,147 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,372 | $789.03 | 57.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 13 | $910.00 | $401.41 | 44.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 374 | 431 | $134,472 | $69,103 | 51.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 322 | 939 | $103,290 | $54,216 | 52.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 93 | $13,950 | $8,880 | 63.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $6,300 | $3,430 | 54.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 28 | $6,328 | $3,334 | 52.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 36 | $3,528 | $2,408 | 68.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 21 | 23 | $1,581 | $964.62 | 61.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 382 | 437 | $136,344 | $68,274 | 50.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 350 | 1,219 | $134,090 | $67,853 | 50.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 76 | $11,400 | $5,774 | 50.6% |
About Dr. Ivan Guerrero, MD
Dr. Ivan Guerrero, MD is a Infectious Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326016536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Guerrero, MD has received a total of $26,872 in payments from pharmaceutical and medical device companies, with $1,889 received in 2024. These payments were reported across 710 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($13,409).
As a Medicare-enrolled provider, Guerrero has provided services to 3,290 Medicare beneficiaries, totaling 5,888 services with total Medicare billing of $496,747. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Jacksonville, FL
- Active Since 03/14/2006
- Last Updated 07/26/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1326016536
Products in Payments
- DOVATO (Drug) $5,400
- SYMTUZA (Drug) $1,047
- Arikayce (Drug) $624.21
- PIFELTRO (Drug) $601.52
- EGRIFTA (Drug) $594.10
- TIVICAY (Drug) $559.00
- PREZCOBIX (Drug) $473.16
- DIFICID (Drug) $407.99
- ISENTRESS (Drug) $394.54
- JULUCA (Drug) $332.02
- TROGARZO (Drug) $300.00
- APRETUDE (Biological) $275.99
- TEFLARO (Drug) $260.28
- RUKOBIA (Drug) $247.49
- Symtuza (Drug) $247.16
- Hizentra (Biological) $240.92
- Mavyret (Drug) $233.04
- Santyl (Drug) $223.80
- AVYCAZ (Drug) $213.10
- ZERBAXA (Drug) $202.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Jacksonville
Dr. Pablo Pella, Md, MD
Infectious Disease — Payments: $139,265
Infectious Disease $139,265
Daniela Chiriboga-Salazar, M.d, M.D
Infectious Disease — Payments: $77,648
Infectious Disease $77,648
Mohammed Reza, Md, MD
Infectious Disease — Payments: $56,351
Infectious Disease $56,351
Robert Catalla, Md, MD
Infectious Disease — Payments: $48,830
Infectious Disease $48,830
Shalika Katugaha, Md, MD
Infectious Disease — Payments: $40,883
Infectious Disease $40,883
Julio Mendez, Md, MD
Infectious Disease — Payments: $21,357
Infectious Disease $21,357